Marine Compounds, Mitochondria, and Malignancy: A Therapeutic Nexus

Mar Drugs. 2022 Sep 30;20(10):625. doi: 10.3390/md20100625.

Abstract

The marine environment is important yet generally underexplored. It contains new sources of functional constituents that can affect various pathways in food processing, storage, and fortification. Bioactive secondary metabolites produced by marine microorganisms may have significant potential applications for humans. Various components isolated from disparate marine microorganisms, including fungi, microalgae, bacteria, and myxomycetes, showed considerable biological effects, such as anticancer, antioxidant, antiviral, antibacterial, and neuroprotective activities. Growing studies are revealing that potential anticancer effects of marine agents could be achieved through the modulation of several organelles. Mitochondria are known organelles that influence growth, differentiation, and death of cells via influencing the biosynthetic, bioenergetic, and various signaling pathways related to oxidative stress and cellular metabolism. Consequently, mitochondria play an essential role in tumorigenesis and cancer treatments by adapting to alterations in environmental and cellular conditions. The growing interest in marine-derived anticancer agents, combined with the development and progression of novel technology in the extraction and cultures of marine life, led to revelations of new compounds with meaningful pharmacological applications. This is the first critical review on marine-derived anticancer agents that have the potential for targeting mitochondrial function during tumorigenesis. This study aims to provide promising strategies in cancer prevention and treatment.

Keywords: anticancer activities; marine compounds; marine microorganisms; mitochondria.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Antiviral Agents / pharmacology
  • Aquatic Organisms
  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • Carcinogenesis
  • Humans
  • Mitochondria
  • Neoplasms* / drug therapy

Substances

  • Antioxidants
  • Antineoplastic Agents
  • Anti-Bacterial Agents
  • Antiviral Agents
  • Biological Products

Grants and funding

This research received no external funding.